Sorry, you need to enable JavaScript to visit this website.

Pfizer supports the global healthcare community’s independent initiatives (e.g., research, quality improvement or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies.

Pfizer’s competitive grant program involves a publicly posted Request for Proposal (RFP) that provides detail regarding a specific area of interest and sets timelines for review and approval. Organizations are invited to submit an application addressing the specific gaps in research, practice or care as outlined in the specific RFP. The grant requester (and ultimately the grantee) is responsible for the design, implementation, sponsorship, and conduct of the independent initiative supported by the grant, including compliance with any regulatory requirements.

Sign-up to receive all GMG announcements, including Request for Proposal (RFP) postings.

Sign Up for Alerts Details
  • Title
    Grant Type
    Focus Area
    Country
    Application Due Date
    Clinical Data Updates & Treatment Management Strategies in First-line ALK-positive Metastatic Non-Small Cell Lung Cancer(NSCLC)
    Release Date:
    Review Process: Pfizer Internal
    Education Oncology USA
    BOOST - Multiple Myeloma An Oncology Boosting Program
    Release Date:
    Review Process: Expert Review Panel
    Translation:(link)
    Quality Improvement Oncology Netherlands
    PARP-Inhibitor Combination Treatments: Safety and Efficacy in a rapidly changing mCRPC landscape
    Release Date:
    Review Process: Pfizer Internal
    Education Oncology All
    Education in the Era of Emerging Hemophilia Therapy
    Release Date:
    Partner: National Bleeding Disorders Foundation
    Review Process: Expert Review Panel
    Education Rare Disease Guam, Puerto Rico, USA
    Education for Patients and Caregivers Living with Bladder Cancer from NMIBC to la/mUC
    Release Date:
    Review Process: Pfizer Internal
    Education Oncology USA
    USP <797> Pharmaceutical Compounding-Sterile Preparations: Ensuring Compliance Now and For the Future
    Release Date:
    Review Process: Pfizer Internal
    Education Hospital USA
    COVID-19 Burden and Benefit of Vaccination - Global excluding US, Canada and Taiwan
    Release Date:
    Review Process: Pfizer Internal
    Education Vaccines All
  • Title
    Grant Type
    Focus Area
    Country
    Application Due Date
    2023 Inflammatory Bowel Disease (IBD) Fellowship
    Release Date:
    Review Process: Expert Review Panel
    Fellowship Inflammation & Immunology USA
    Advances in the Management of Ulcerative Colitis (UC)
    Release Date:
    Review Process: Pfizer Internal
    Education Inflammation & Immunology USA
    Knowledge Gaps in Managing High-Risk Patients and COVID-19
    Release Date:
    Review Process: Pfizer Internal
    Education Hospital USA
    2023 Bladder Cancer Canada-EMD Serono-Pfizer Quality Improvement Request for Proposals
    Release Date:
    Partner: Bladder Cancer Canada; EMD Serono
    Review Process: Expert Review Panel
    Translation: French (link)
    Quality Improvement Oncology Canada
    Relapsed/Refractory Multiple Myeloma (North America and Europe)
    Release Date:
    Review Process: Pfizer Internal
    Education Oncology All
    Improving Metastatic Breast Cancer (mBC) Quality of Care and Equity in Latin America
    Release Date:
    Partner: Conquer Cancer, the ASCO Foundation
    Review Process: Expert Review Panel
    Translation:(link)
    Translation: Spanish (link)
    Quality Improvement Oncology All
    Junior Investigator Global ATTR Amyloidosis Research ASPIRE (All countries except for the United States)
    Release Date:
    Review Process: Expert Review Panel
    Research Rare Disease All
    Call for Independent Medical Education Grant Applications Oncology – Prostate Cancer
    Release Date:
    Partner: Astellas
    Review Process: Pfizer Internal
    Education Oncology USA
    Improving the Care of Patients Living with Metastatic Breast Cancer (mBC)
    Release Date:
    Partner: Rethink Breast Cancer
    Review Process: Expert Review Panel
    Translation: French (link)
    Quality Improvement Oncology Canada
    REI: Advisory Group for Patient-Reported Outcome Implementation in Vulnerable and Underserved Populations
    Release Date:
    Partner: The PROTEUS Consortium
    Review Process: Expert Review Panel
    Quality Improvement Oncology USA
    Improving the quality of care of patients with urothelial cancer
    Release Date:
    Partner: Merck Serono
    Review Process: Expert Review Panel
    Quality Improvement Oncology Italy
    Mental Health in Rheumatology
    Release Date:
    Review Process: Pfizer Internal
    Quality Improvement Inflammation & Immunology Canada